A novel approach to oral apoA-I mimetic therapy (vol 54. pg 995, 2013)

被引：5
|
作者：
Chattopadhyay, Arnab
机构：
来源：
JOURNAL OF LIPID RESEARCH | 2013年 / 54卷 / 11期
关键词：
D O I：
10.1194/jlr.M033555ERR
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：3220 / 3220
页数：1
相关论文
共 50 条
  • [21] Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux (vol 8, e67993, 2013)
    Daniil, G.
    Zannis, V., I
    Chroni, A.
    PLOS ONE, 2014, 9 (09):
  • [22] a novel approach for cancer therapy (vol 22, pg 14, 2014)
    Liu, Tianyu
    Li, Qingyong
    JOURNAL OF DRUG TARGETING, 2014, 22 (03) : 267 - 267
  • [23] A novel approach to collaborative testing in a crowdsourcing environment (vol 86, pg 2143, 2013)
    Tung, Yuan-Hsin
    Tseng, Shian-Shyong
    Tsai, Wei-Tek
    JOURNAL OF SYSTEMS AND SOFTWARE, 2014, 87 : 137 - 137
  • [24] RETRACTION: A novel approach for the treatment of dysphagia lusoria (Retraction of Vol 43, Pg 434, 2013)
    Venugopal, Ram Rao
    Kolwalkar, Jagannath Premanand
    Krishnajirao, Sunil Putane
    Narayan, Madhusudana
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2019, 55 (06) : 1242 - 1242
  • [25] RETINOIDS STIMULATE APOA-I SYNTHESIS BY INDUCTION OF GENE-TRANSCRIPTION IN PRIMARY HEPATOCYTE CULTURES FROM CYNOMOLGUS MONKEY (MACACA-FASCICULARIS) (VOL 13, PG 1505, 1993)
    KAPTEIN, A
    DEWIT, ECM
    ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05): : 839 - 839
  • [26] Somatic gene therapy for long-term stable correction of genetic HDL deficiency and atherosclerotic disease in mice using a novel nontoxic adenoviral human ApoA-I vector
    Belalcazar, LM
    Merched, A
    Carr, B
    Antanova, E
    Chen, KH
    Oka, K
    Pastore, L
    Beaudet, A
    Chan, L
    CIRCULATION, 2000, 102 (18) : 163 - 164
  • [27] Oral estradiol and dydrogesterone combination therapy in postmenopausal women: Review of efficacy and safety (vol 76, pg 10, 2013)
    Stevenson, John C.
    Panay, Nicholas
    Pexman-Fieth, Claire
    MATURITAS, 2013, 76 (04) : 388 - 388
  • [28] RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease (vol 247, pg 48, 2016)
    Gilham, Dean
    Wasiak, Sylwia
    Tsujikawa, Laura M.
    Halliday, Christopher
    Norek, Karen
    Patel, Reena G.
    Kulikowski, Ewelina
    Johansson, Jan
    Sweeney, Michael
    Wong, Norman C. W.
    ATHEROSCLEROSIS, 2016, 253 : 345 - 345
  • [29] A novel apoA-I mutation (Leu178Pro), identified by whole genome linkage approach, predisposes to endothelial dysfunction, increased arterial wall thickness and premature coronary artery disease
    Hovingh, GK
    Bisoendial, RJ
    Brownlie, A
    Samuels, M
    Kuivenhoven, JA
    De Groot, E
    Stroes, ESG
    Hayden, MR
    Kastelein, JJP
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 27 - 27
  • [30] Pityriasis folliculorum: A novel therapy for a diagnostically challenging condition. (vol 69, pg e276, 2013)
    Tinklepaugh, Adam J.
    Wilson, Barbara B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) : 399 - 399
12345